• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    BMS Announces Positive Results from Registrational Phase 2 Study

    PHARMIWEB

    BMS`s Breyanzi Is First CAR-T Approved in US for Rare Lymphoma

    BUSINESSWIRE

    US FDA approves Citius` therapy for rare blood cancer

    REUTERS

    Argenx`s Vyvgart Competes Well With AstraZeneca In Myasthenia Gravis

    FIERCE PHARMA

    Biogen, Roche ink deals with Bristol for rare disease drugs

    BIOPHARMADIVE

    LAM raises $58M for cancer, rare disease pipeline; What do you pray for?

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.